167 related articles for article (PubMed ID: 35353808)
21. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
Toth AM; Li Z; Cattaneo R; Samuel CE
J Biol Chem; 2009 Oct; 284(43):29350-6. PubMed ID: 19710021
[TBL] [Abstract][Full Text] [Related]
22. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
23. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
24. 5-HT
Yu W; Xu H; Xue Y; An D; Li H; Chen W; Yu D; Sun Y; Ma J; Tang Y; Xiao Z; Yin S
Brain Behav; 2018 Mar; 8(3):e00929. PubMed ID: 29541541
[TBL] [Abstract][Full Text] [Related]
25. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
[TBL] [Abstract][Full Text] [Related]
26. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
Crooke PS; Tossberg JT; Porter KP; Aune TM
J Immunol; 2021 Apr; 206(8):1691-1696. PubMed ID: 33782089
[TBL] [Abstract][Full Text] [Related]
27. Modulation of ADAR1 editing activity by Z-RNA in vitro.
Koeris M; Funke L; Shrestha J; Rich A; Maas S
Nucleic Acids Res; 2005; 33(16):5362-70. PubMed ID: 16177183
[TBL] [Abstract][Full Text] [Related]
28. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K
J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813
[TBL] [Abstract][Full Text] [Related]
29. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
[TBL] [Abstract][Full Text] [Related]
30. Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2.
Zong J; Zhang Y; Guo F; Wang C; Li H; Lin G; Jiang W; Song X; Zhang X; Huang F; Qi M; Zheng X
J Appl Genet; 2022 May; 63(2):413-421. PubMed ID: 35179717
[No Abstract] [Full Text] [Related]
31. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
Liu Y; Emeson RB; Samuel CE
J Biol Chem; 1999 Jun; 274(26):18351-8. PubMed ID: 10373439
[TBL] [Abstract][Full Text] [Related]
32. A-to-I editing of Malacoherpesviridae RNAs supports the antiviral role of ADAR1 in mollusks.
Rosani U; Bai CM; Maso L; Shapiro M; Abbadi M; Domeneghetti S; Wang CM; Cendron L; MacCarthy T; Venier P
BMC Evol Biol; 2019 Jul; 19(1):149. PubMed ID: 31337330
[TBL] [Abstract][Full Text] [Related]
33. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
George CX; John L; Samuel CE
J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
[TBL] [Abstract][Full Text] [Related]
34. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
36. RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure.
Solomon O; Di Segni A; Cesarkas K; Porath HT; Marcu-Malina V; Mizrahi O; Stern-Ginossar N; Kol N; Farage-Barhom S; Glick-Saar E; Lerenthal Y; Levanon EY; Amariglio N; Unger R; Goldstein I; Eyal E; Rechavi G
Nat Commun; 2017 Nov; 8(1):1440. PubMed ID: 29129909
[TBL] [Abstract][Full Text] [Related]
37. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
38. The Other Face of an Editor: ADAR1 Functions in Editing-Independent Ways.
Licht K; Jantsch MF
Bioessays; 2017 Nov; 39(11):. PubMed ID: 28960389
[TBL] [Abstract][Full Text] [Related]
39. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
Liu Y; Samuel CE
J Biol Chem; 1999 Feb; 274(8):5070-7. PubMed ID: 9988754
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression.
Jayan GC; Casey JL
J Virol; 2002 Dec; 76(23):12399-404. PubMed ID: 12414985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
